Key Insights

Highlights

Success Rate

97% trial completion (above average)

Published Results

48 trials with published results (7%)

Research Maturity

487 completed trials (74% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.1%

14 terminated out of 654 trials

Success Rate

97.2%

+10.7% vs benchmark

Late-Stage Pipeline

1%

7 trials in Phase 3/4

Results Transparency

10%

48 of 487 completed with results

Key Signals

48 with results97% success14 terminated

Data Visualizations

Phase Distribution

598Total
Not Applicable (71)
Early P 1 (7)
P 1 (498)
P 2 (15)
P 3 (3)
P 4 (4)

Trial Status

Completed487
Recruiting78
Not Yet Recruiting28
Active Not Recruiting19
Unknown19
Terminated14

Trial Success Rate

97.2%

Benchmark: 86.5%

Based on 487 completed trials

Clinical Trials (654)

Showing 20 of 20 trials
NCT06690294Not Yet RecruitingPrimary

Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism

NCT06274749Not ApplicableRecruitingPrimary

Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial

NCT07313787Phase 2Not Yet Recruiting

Effects of Meal Macronutrients on Postprandial Lipids

NCT05652478Phase 2RecruitingPrimary

Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized Study

NCT07514260Phase 1RecruitingPrimary

A Study to Assess Adverse Events, Tolerability, and Pharmacokinetics of Subcutaneous Injections of ABBV-295 in Healthy Adult Japanese Participants With Overweight or Obesity.

NCT03878121Phase 1RecruitingPrimary

Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers

NCT04274998Early Phase 1Active Not Recruiting

Neuroinflammation Imaging in AD

NCT00090662RecruitingPrimary

Collection of Data and Samples From Healthy Donors for Use in Translational Research

NCT01934660Completed

Links Between Inflammation and Cardiometabolic Diseases

NCT00004577RecruitingPrimary

Study of New Magnetic Resonance Imaging Methods of the Brain

NCT07527923Phase 1Not Yet RecruitingPrimary

First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis

NCT01629108RecruitingPrimary

Normal Values in Hearing and Balance Testing

NCT07526519Phase 1RecruitingPrimary

A Safety and Pharmacokinetics Study of TL-001 in Healthy Adults and Open-label Assessments in Participants With Ulcerative Colitis

NCT07526506Phase 1RecruitingPrimary

Study of TRX-100 Tablets Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy Volunteers

NCT07439263Phase 1RecruitingPrimary

Single Ascending Dose Study of HB2198 in Healthy Participants

NCT07284576Phase 2Enrolling By InvitationPrimary

Ultralow Dose PET Imaging of 18F-flurpiridaz

NCT01266577Not ApplicableRecruiting

Development of Magnetic Resonance Spectroscopic Imaging Techniques for Imaging Metabolites in Human Brain and Muscle

NCT07526116Phase 1Not Yet RecruitingPrimary

A First in Human Study to Assess Safety, Tolerability and Pharmacokinetics of a Single Dose of REGN22044 in Healthy Adults

NCT00001360RecruitingPrimary

Studies of Blood Flow to the Brain During Thought

NCT07516405Phase 1RecruitingPrimary

Safety and Tolerability Trial of Psilocybin in Healthy Older Adults

Scroll to load more

Research Network

Activity Timeline